HK1217268A2 - α- 種 α- 幹細胞及其製備方法和應用 - Google Patents

α- 種 α- 幹細胞及其製備方法和應用

Info

Publication number
HK1217268A2
HK1217268A2 HK16105540.6A HK16105540A HK1217268A2 HK 1217268 A2 HK1217268 A2 HK 1217268A2 HK 16105540 A HK16105540 A HK 16105540A HK 1217268 A2 HK1217268 A2 HK 1217268A2
Authority
HK
Hong Kong
Prior art keywords
msc
tnf
application
stem cells
engineered stem
Prior art date
Application number
HK16105540.6A
Other languages
English (en)
Inventor
連祺周
Original Assignee
中基恆潤國際控股有限公司 號
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中基恆潤國際控股有限公司 號 filed Critical 中基恆潤國際控股有限公司 號
Priority to HK16105540.6A priority Critical patent/HK1217268A2/zh
Priority to CN201611200969.9A priority patent/CN107034217A/zh
Publication of HK1217268A2 publication Critical patent/HK1217268A2/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16105540.6A 2016-05-16 2016-05-16 α- 種 α- 幹細胞及其製備方法和應用 HK1217268A2 (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HK16105540.6A HK1217268A2 (zh) 2016-05-16 2016-05-16 α- 種 α- 幹細胞及其製備方法和應用
CN201611200969.9A CN107034217A (zh) 2016-05-16 2016-12-22 启动子、重组间质干细胞及其制备方法和应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK16105540.6A HK1217268A2 (zh) 2016-05-16 2016-05-16 α- 種 α- 幹細胞及其製備方法和應用

Publications (1)

Publication Number Publication Date
HK1217268A2 true HK1217268A2 (zh) 2016-12-30

Family

ID=57610765

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105540.6A HK1217268A2 (zh) 2016-05-16 2016-05-16 α- 種 α- 幹細胞及其製備方法和應用

Country Status (2)

Country Link
CN (1) CN107034217A (zh)
HK (1) HK1217268A2 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110951693A (zh) * 2019-12-05 2020-04-03 北京兴元和济生命医学科技有限公司 一种利用CRISPR-Cas9系统对间充质干细胞定点敲入外源基因的方法
CN114934070B (zh) * 2022-01-18 2023-05-02 生物岛实验室 间充质干细胞及其抗炎应用

Also Published As

Publication number Publication date
CN107034217A (zh) 2017-08-11

Similar Documents

Publication Publication Date Title
HK1250481A1 (zh) 經過修飾的t細胞及其製備和使用方法
EP3119532A4 (en) Treated article and method of making the same
ZA201808411B (en) Container and method of manufacturing the same
GB201622340D0 (en) Product and Method
PT3036748T (pt) Indutor e respetivo método de fabrico
ZA201806999B (en) Labeller and method of using the same
PL3170912T3 (pl) Produkt stalowy oraz sposób jego wytwarzania
IL263341A (en) Stem cell material, compounds and methods of use
GB201707059D0 (en) Noscapinoid-producing microbes and methods of making and using the same
EP3316828A4 (en) TECHNICAL MATERIALS AND METHOD FOR THE PRODUCTION THEREOF
PL3093358T3 (pl) Stal i sposób jej wytwarzania
EP3233124A4 (en) Nanowire-coated microdevice and method of making and using the same
KR101822784B9 (ko) 신경혈관단위-온-칩 및 그 칩의 제조방법
PL3127605T3 (pl) Sposób wytwarzania wypełnienia oraz wypełnienie
GB201609584D0 (en) A de-oiler and a method of using the same
IL252529B (en) Stem cell material and methods of preparation
GB2544343B (en) Receptacle and its method of manufacture
PL3247651T3 (pl) Pojemnik ze środkiem do traktowania oraz sposób jego wytwarzania
GB201502267D0 (en) Cosmetic palette assembly and method of making the same
HK1217268A2 (zh) α- 種 α- 幹細胞及其製備方法和應用
EP3209262A4 (en) Memorial object and method of making the same
PL3199370T3 (pl) Sposób wytwarzania i urządzenie do zastosowania sposobu wytwarzania
GB2543130B (en) Improved coatings and method of applying the same
IL246493A0 (en) tool and method to produce it
IL242952A0 (en) An array of detectors and a method to create it

Legal Events

Date Code Title Description
PF2 Short-term patent ceased to have effect under s.126(2) (not payment of maintenance fee and has 6-month grace period to pay)

Effective date: 20200516